VAERS reports by lot

GSK Varicella/Shingles lot 57EX2: VAERS reports

22 VAERS reports list lot 57EX2 as a GSK Varicella/Shingles vaccine, received between 2020-07-23 and 2023-11-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
9%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1819%
Neurological1617%
Injection-site / Local reaction1516%
Cardiac / Cardiovascular1213%
Dermatological (non-injection-site)1112%
Musculoskeletal910%
Allergic / Anaphylactic55%
Gastrointestinal44%
Respiratory22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 9).

California11
Arizona3
Montana1
Minnesota1
Pennsylvania1
Nebraska1
Alaska1
Washington1
Colorado1

Reports by month received

2020-072
2020-081
2020-095
2020-102
2020-112
2020-122
2021-011
2021-021
2021-051
2021-071
2021-101
2021-111
2022-021
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.